Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,415 USD | -1,92% | +9,96% | +108,33% |
Vakgebied
Aantal werknemers: 328
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steven Harr
FOU | Founder | 53 | 13-07-18 |
Nathan Hardy
DFI | Director of Finance/CFO | 48 | 01-09-18 |
Gary Meininger
CTO | Chief Tech/Sci/R&D Officer | - | 10-04-23 |
Shanna Peek
COO | Chief Operating Officer | - | 01-07-19 |
Edward Rebar
CTO | Chief Tech/Sci/R&D Officer | 56 | 01-03-20 |
Richard Mulligan
CTO | Chief Tech/Sci/R&D Officer | 69 | 01-11-18 |
Ke Liu
LAW | General Counsel | - | 06-01-21 |
Sonja Schrepfer
PRN | Corporate Officer/Principal | 49 | 01-02-19 |
Steven Goldman
PRN | Corporate Officer/Principal | 66 | 01-10-20 |
Terry Fry
PRN | Corporate Officer/Principal | 57 | 01-08-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 69 | 01-05-20 | |
Patrick Yang
BRD | Director/Board Member | 75 | 01-10-18 |
Robert Nelsen
FOU | Founder | 60 | 13-07-18 |
Douglas Cole
BRD | Director/Board Member | 63 | 01-04-20 |
Steven Harr
FOU | Founder | 53 | 13-07-18 |
Josh Bilenker
BRD | Director/Board Member | 52 | 08-01-21 |
Richard Mulligan
CTO | Chief Tech/Sci/R&D Officer | 69 | 01-11-18 |
Hans Bishop
FOU | Founder | 59 | 13-07-18 |
Michelle Seitz
BRD | Director/Board Member | 59 | 01-12-20 |
Alise Reicin
BRD | Director/Board Member | 63 | 01-12-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 218 835 612 | 198 786 916 ( 90,84 %) | 0 | 90,84 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+108,33% | 1,89 mld. | |
+0,96% | 43,84 mld. | |
+4,81% | 41,68 mld. | |
+45,43% | 41,25 mld. | |
-11,96% | 27,04 mld. | |
+6,38% | 25,53 mld. | |
-25,32% | 18,18 mld. | |
-3,57% | 12,29 mld. | |
+25,43% | 12,29 mld. | |
+6,85% | 11,15 mld. |
- Beurs
- Aandelen
- Koers SANA
- Onderneming Sana Biotechnology, Inc.